Back

Featured Topics

Behind The Science
Breast Cancer
Cancer Immunotherapy
Hematology
Lung Cancer
Manufacturing
Multiple Sclerosis
Oncology
Ophthalmology
Partnering
Respiratory Health
Rheumatology
About Us Contact Us Leadership Awards & Recognition Investors Suppliers Compliance
Genentech - A Member of the Roche Group
  • Share
  • Twitter
  • Facebook
  • LinkedIn
  • Email
  • Twitter
  • Facebook
  • LinkedIn
  • Email

Making the Pledge


Read More Stories
Oct 20, 2016

Greg Orlick

A Genentech employee living with MS.


Can Do Day is an annual event held on September 22 by Can Do Multiple Sclerosis (MS) that celebrates people with MS and all they can do to live passionately and love life. This year, our employees joined hundreds of people in making “Can Do” pledges. We’ve featured a few of those pledges here, along with the story behind the pledge made by Greg Orlick, one of our employees who also has MS.



Seventeen years ago, MS looked very different to me than it does now. I wanted to deal with the disease on my terms. I didn’t even tell my family about my diagnosis right away.

Then I met John. He was probably twice my age. He’d been a star baseball player at the University of Virginia and a prominent attorney. He stopped practicing law when he got MS, and he was using a motorized wheelchair when I met him. But John was still going, using his experience to advocate for MS patients and people with disabilities at the state and federal levels. He leveraged his disability to do great things.

Genentech employee Greg, cooking with his wife Sonya, has made a pledge to thank those who have supported him and the MS community.

I think about John every time I talk to someone newly diagnosed with MS. I wonder how John’s life might have been different if he’d been able to access some of the medicines I’ve been able to access. And I realize that those diagnosed today will also see the disease differently, because they will have access to even better and more transformative therapies than me.

MS isn’t the end – it just changes how you approach life. I’ve made it my purpose to help others deal with the disease. Just the other day, two Genentech colleagues asked me how to best support loved ones who had just been diagnosed. It turns out it’s often easier to talk to a stranger about MS – and patients often feel like they only want to talk to someone else who has it.

I didn’t start cooking until 10 years ago. My mom was in shock when I started. But now, I have a full chef’s kitchen! Cooking is the only creative thing that I do. Earlier this year, I heard a talk by a professional chef who battled her own MS by cooking Italian feasts each week for a year. That inspired me! My wife, Sonya, and I are so grateful to all of the people who donate to our MS fundraising team, so we’re committing this year to thank all of our donors by hosting small dinners. We’ll pay back their generosity through food, wine and friendship.

I made my Can Do Day pledge in honor of John, my friends and family and all the people I’ve met who have MS. And I’m proud that so many of my colleagues – and my company – are standing in solidarity with me and others with this disease.



Genentech employees joined Greg to rally behind the MS community and submit their own Can Do Day pledges. Here are a few:

   of  

Read more Can Do Day pledges at the Can Do MS website.

Learn more about Greg’s story and his diagnosis.


Tags:

  • Multiple Sclerosis

Read More Stories


The Last Mile

Shanthi Sekaran

Just 11 hours after a medicine for metastatic breast cancer was FDA-approved, it was on the way to a patient who needed it.

A Revolutionary Partnership: The Story of PDUFA

Michelle Rohrer, PhD

The remarkable history behind an unprecedented collaborative effort to get medicines to patients faster.

Understanding Idiopathic Pulmonary Fibrosis

Genentech

Learn about the key aspects of idiopathic pulmonary fibrosis (IPF) and test your knowledge as you go with our interactive quizzes.

Feedback?

Tell us what you think about our company, products, or website.

“
The way to do research is to attack the facts at the point of greatest astonishment.
” – Celia Green
Genentech - A Member of the Roche Group
  • Now Hiring
  • Work Here
  • University & Early Career
  • Professional Areas
  • For Scientists
  • Our Scientists
  • Publications
  • Oncology
  • Immunology
  • Neuroscience
  • Metabolism
  • Infectious Disease
  • Ophthalmology
  • For Patients
  • Our Medicines
  • Investigational Medicines
  • Patient Access
  • Disease Education
  • For Medical Professionals
  • Our Medicines
  • Our Pipeline
  • Medical Resources
  • Sunshine Act Compliance
  • Product Security
  • For Partners
  • Our Approach
  • Our Relationship with Roche
  • Partner With Us
  • Our Stories
  • For Media
  • News Features
  • Press Releases
  • Statements
  • Company Information
  • Product Information
  • Sign Up For News Alerts
  • For Good
  • Local Initiatives
  • Giving
  • Diversity & Inclusion
  • Environmental Sustainability
  • About Us
  • Leadership
  • Awards & Recognition
  • Investors
  • Suppliers
  • CA Transparency in Supply
  • Compliance Overview
  • Contact Us
  • Call Us
  • Email Us
  • Connect with us
  • Visit us
  • Submit a Medical Inquiry
Genentech - A Member of the Roche Group
Connect with us
Privacy Policy  |  Terms & Conditions
Genentech, Inc. © 2018